Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lysosomal alpha-mannosidase (LAMAN) is an acidic exoglycosidase enzyme essential for the catabolism of N-linked carbohydrates released during glycoprotein turnover. It cleaves α-1,2, α-1,3, and α-1,6 mannosidic linkages in oligosaccharides within lysosomes. Deficiency or dysfunction of LAMAN leads to alpha-mannosidosis, a rare autosomal recessive lysosomal storage disorder characterized by accumulation of undegraded oligosaccharides within cells. Mutations in MAN2B1 are responsible for this disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lysosomal alpha-mannosidase.